Gastroesophageal Reflux Disease (GERD) is a common yet complex condition, affecting nearly 20% of the Western population. Its diagnosis and treatment require a comprehensive understanding of its pathophysiology and the latest therapeutic approaches.
GERD diagnosis is primarily clinical, relying heavily on patient-reported symptoms. However, objective tests like endoscopy, esophageal manometry, and ambulatory pH monitoring can provide valuable insight. Endoscopy is useful in assessing mucosal damage and excluding other disorders. Esophageal manometry evaluates esophageal motility, while ambulatory pH monitoring measures acid exposure in the esophagus, confirming the diagnosis in equivocal cases.
Proton pump inhibitors (PPIs) are the mainstay of GERD treatment, providing symptom relief and healing esophagitis. However, a subset of patients may not respond adequately to PPIs, necessitating the exploration of alternative therapeutic strategies.
For patients with refractory GERD, surgical interventions such as laparoscopic Nissen fundoplication can provide long-term symptom relief. Recent advancements also include minimally invasive endoscopic techniques like Stretta and Transoral Incisionless Fundoplication (TIF). These procedures aim to augment the lower esophageal sphincter, reducing gastroesophageal reflux.
Emerging therapies for GERD include novel pharmacological agents targeting different pathophysiological mechanisms, such as reflux inhibitors and esophageal mucosal protectants. Additionally, the role of dietary interventions and gut microbiota modulation in GERD management is increasingly recognized and warrants further research.
GERD is a multifaceted disorder with a broad spectrum of clinical presentations. Its effective management requires a comprehensive approach, incorporating accurate diagnosis, optimal use of pharmacotherapy, and consideration of advanced treatment options in refractory cases. As our understanding of GERD pathophysiology expands, it paves the way for novel therapeutic strategies, promising improved patient outcomes.
1.
Race, Geography Linked to Gaps in Prostate Cancer Care
2.
Sports for girls are frequently abandoned due to uniform issues.
3.
According to the Lancet, having cancer and VTE at the same time increases mortality risk.
4.
Temsirolimus Plus Chemotherapy Fails in Rare Childhood Cancer
5.
Nivolumab Regimen Achieves Durable PFS in Advanced Hodgkin's Lymphoma
1.
Hematopoietic Clonal Competition in Blood Disorders
2.
Managing KRAS Inhibitor Toxicities: Focus on Rash and Beyond
3.
Developmental Iron Biology Beyond Infancy: Mechanisms, Clinical Implications, and Emerging Directions
4.
Next-Generation Bone Marrow Harvest Technologies
5.
Strategic Applications in Hematology in Clinical Decision-Making
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Understanding the Common Causes of Anemia
2.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
3.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
4.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation